- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Momenta Pharmaceuticals Inc
+ Add to WatchlistMNTA:US
13.3900 USD 0.0800 0.60%As of 20:10:00 ET on 05/24/2013.
Snapshot for Momenta Pharmaceuticals Inc (MNTA)
| Open: | 13.2600 | Day's Range: | 13.1100 - 13.5000 | Volume: | 127,305 |
|---|---|---|---|---|---|
| Previous Close: | 13.3900 | 52wk Range: | 10.0500 - 17.0900 | 1-Yr Rtn: | -2.83% |
Key Statistics for MNTA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.5400 |
| Est. EPS (USD) (12/2013) | -1.8750 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 695.28 |
| Shares Outstanding (M) | 51.93 |
| 30 Day Average Volume | 303,338 |
| Price/Book (mrq) | 2.0447 |
| Price/Sale (ttm) | 14.2876 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MNTA
Company Profile & Key Executives for MNTA
Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.
| Craig A WheelerPresident/CEO | Richard P Shea "Rick"Senior VP/CFO |
| Bruce A LeicherSenior VP/Secy/General Cnsl | James M RoachSenior VP:Development/CMO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MNTA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page